Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sterol O-acyltransferase 2 (SOAT2), also known as acyl-CoA:cholesterol acyltransferase 2 (ACAT2), is an endoplasmic reticulum membrane-bound enzyme predominantly expressed in hepatocytes and enterocytes. It plays a critical role in systemic cholesterol homeostasis by catalyzing the esterification of free cholesterol with long-chain fatty acyl-CoA to form cholesteryl esters, which are subsequently packaged into apolipoprotein B-containing lipoproteins (such as VLDL and chylomicrons) or stored as intracellular lipid droplets. Due to its central role in dietary cholesterol absorption and hepatic lipoprotein secretion, SOAT2 is a major therapeutic target for cardiovascular diseases, hypercholesterolemia, and atherosclerosis. Additionally, emerging evidence implicates SOAT2 in cancer progression, particularly in hepatocellular carcinoma, lung adenocarcinoma, and ovarian cancer, where its upregulation helps prevent free cholesterol-induced cytotoxicity and supports tumor cell survival. Pharmacological targeting of SOAT2 has evolved from non-selective dual SOAT1/SOAT2 inhibitors like avasimibe and pactimibe, which faced clinical development challenges, to highly selective SOAT2 inhibitors such as pyripyropene A and its derivatives, which demonstrate robust lipid-lowering and anti-atherosclerotic efficacy with improved safety profiles in preclinical models.
Inhibition of sterol O-acyltransferase 2 activity to reduce cholesterol esterification
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sterol O-acyltransferase 2 (SOAT2).